- About Us
- Advertise
- Contact Us
- Editorial Staff
- Privacy Policy
- Terms & Conditions
- Do Not Sell My Information
© 2022 MJH Life Sciences™ , Pharmacy Times – Pharmacy Practice News and Expert Insights. All rights reserved.
January/February 2015
Managing Care and Costs for Orphan Conditions
February 09, 2015
Article
Features
The number of drugs approved for orphan conditions has increased in recent years, and specialty pharmacies play an important role in the management of therapies for patients with rare diseases.
Alternative to IVIG Reduces Antibodies in Kidney Patients
February 09, 2015
Article
Disease State Management
Viekira Pak by AbbVie Inc
February 09, 2015
Article
New Drug Review
Viekira Pak is an all-oral regimen that has been approved by the FDA for the treatment of genotype 1 chronic hepatitis C virus infection.
Hemolytic Anemia May Develop After High-Dose IVIG Treatment
February 09, 2015
Article
Disease State Management
Passive Antibody Transfer May Occur Following IVIG Transfusion
February 09, 2015
Article
Disease State Management
HIV Drugs May Cause Long-Term Damage to Fetal Hearts
February 09, 2015
Article
Disease State Management
Why a Holistic, Technology-Enabled Treatment Approach Is Necessary to Address Hepatitis C-Related Liver Disease
February 09, 2015
Article
Features
Patients with hepatitis C benefit from a collaborative approach that involves specialty pharmacists and other care providers working with patients to promote patient engagement, adherence to therapy, and management of comorbidities.
Specialty Drugs: Year in Review 2014
February 09, 2015
Article
Clinical Insights
In 2014, the FDA approved notable new therapies for the treatment of cancer, bleeding disorders, inflammatory conditions, cystic fibrosis, pulmonary fibrosis, HIV, hepatitis C, multiple sclerosis, angioedema, and other conditions.
Diplomat Sets the Standard for Independent Specialty Pharmacies
February 09, 2015
Article
Innovators & Leaders
Diplomat Pharmacy, Inc, serves patients in all 50 states with a focus on medication management programs tailored to the treatment of complex chronic disease states.
CMS Under Increased Pressure to Make Accurate Payments for Prescription Drugs
February 09, 2015
Article
Washington Insights
The Office of Inspector General has called upon of the Centers for Medicare & Medicaid Services to make the reduction of improper payments for prescription drugs a priority in 2015.
Are the Political Winds Shifting for Medical Marijuana?
February 09, 2015
Article
Viewpoints: The Last Word
A recent congressional spending bill prohibits federal agents from raiding retail medical cannabis operations in states that allow medical marijuana.
The New Paradigm in Specialty: Payer Formulary Control?
February 09, 2015
Article
Editorial
As costly new specialty medications come to market, the role of the payer in controlling formularies is becoming increasingly apparent.
The Future of Hepatitis C Virus Treatment: Implications for Specialty and Community Pharmacy
February 09, 2015
Article
CE Highlights